ClinicalThought

Share

Program Content

Activities

  • Next-Gen BTK Inhibitors
    Next-Generation BTK Inhibitors and Why We Need Them
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 24, 2019

    Expires: October 22, 2020

  • BTK Inhibitor FAQs
    Frequently Asked Questions About BTK Inhibitor Use in B-Cell Malignancies
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 21, 2020

    Expires: February 19, 2021

  • Zanubrutinib in MCL
    Meet Zanubrutinib, the Newest Bruton’s Tyrosine Kinase Inhibitor for Mantle Cell Lymphoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 24, 2020

    Expires: March 23, 2021

Provided by

ProCE Banner

Supporters

AstraZeneca

BeiGene, Ltd.

Loxo Oncology subsidiary of Eli Lilly